News

The MACSima™ Imaging Platform is the only complete solution for ultra high content imaging experiments.

September 13, 2021

At its core it includes the MACSima Imaging System, a fully automated instrument based on fluorescence microscopy. Its MICS (MACSimaTM Imaging Cyclic Staining) technology, together with a broad spectrum of recombinant ready-to-use antibodies, allows the analysis of hundreds of markers on a single sample, multiple samples at a time.

Convenient and easy to use, its specially designed sample carriers allow you to examine any kind of fixed sample, from tissue to single cells, and the powerful and intuitive Qi Tissue Image Analysis Software makes for a truly game-changing imaging experience.

A team of scientists from across Germany, led by Miltenyi Biotec, recently used a smart combination of data mining, flow cytometry, and ultrahigh-content analysis with the MACSima™ Imaging Platform to bypass a major roadblock preventing potential cellular immunotherapy: the lack of suitable tumor-specific antigens.

Visit our booth to learn more about this and get the paper published in Nature Communications.

News

Landau Partnership

September 22, 2021

VectorBuilder Inc., a global leader in vector design, optimization and GMP manufacturing, and Landau Biotechnology Co., a world leader in developing nonhuman primate (NHP) models for clinical research applications, have...

Learn more

Univercells Partnership

September 16, 2021

VectorBuilder – a global leader in vector design, optimization, and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible...

Learn more

New automated process to simplify the manufacturing of gene-engineered hematopoietic stem cells with the CliniMACS Prodigy® HSC Engineering System

September 13, 2021

Learn more

MedXCell SA

August 25, 2021

MedXCell Science SA: MedXCell Science SA was co-founded in 2018 by the University Hospital of Montpellier (CHU of Montpellier) in France and the Swiss company MedXCell SA. It was the...

Learn more

Cryoport Systems now supporting 7 commercial therapies globally

July 27, 2021

Learn more

Polyplus-transfection initiates construction of Vectura, a new 4,000m2 facility

July 23, 2021

Learn more

Polyplus-transfection® launches FectoVIR®-AAV

July 23, 2021

Learn more

RD-Biotech: a new company from Besançon wins the « France Relance » call for projects

February 22, 2021

Following the unprecedented health crisis and its unprecedented economic impact, the Government has put in place numerous tools to support businesses.

Learn more

Covi-TRaC: arming our immune cells against SARS-COV2

September 11, 2020

A prolific period for researchers, confinement has allowed the Etablissement Français du Sang teams to generate and mature many ideas from pre-existing research. In Besançon, Marina Deschamps and Christophe Ferrand...

Learn more